Expression of COX-2 and Prognostic Outcome in Uveal Melanoma

REFERENCES

• Gupta R A, Dubois R N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 2001; 1: 11–21
   PubMed Web of Science ®Google Scholar
• Masferrer J L, Leahy K M, Koki A T, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 2000; 60: 1306–1311
   PubMed Web of Science ®Google Scholar
• Jacoby R F, Seibert K, Cole C E, Kelloff G, Lubet R A. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res. 2000; 60: 5040–5044
   PubMed Web of Science ®Google Scholar
• Kawamori T, Rao C V, Seibert K, Reddy B S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 1998; 58: 409–412
   PubMed Web of Science ®Google Scholar
• Oshima M, Murai N, Kargman S, et al. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res. 2001; 61: 1733–1740
   PubMed Web of Science ®Google Scholar
• Sheng H, Shao J, Kirkland S C, et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest. 1997; 99: 2254–2259
   PubMed Web of Science ®Google Scholar
• Pai R, Soreghan B, Szabo I L, Pavelka M, Baatar D, Tarnawski A S. Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med. 2002; 8: 289–293
   PubMed Web of Science ®Google Scholar
• Sheng H, Shao J, Washington M K, Du Bois R N. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem. 2001; 276: 18075–18081
   PubMed Web of Science ®Google Scholar
• Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois R N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998; 93: 705–716
   PubMed Web of Science ®Google Scholar
• Tsujii M, Kawano S, DuBois R N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 1997; 94: 3336–3340
   PubMed Web of Science ®Google Scholar
• Mudhar H S, Parsons M A, Sisley K, Rundle P, Singh A, Rennie I G. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma. Histopathology. 2004; 45: 1–12
   PubMed Web of Science ®Google Scholar
• Gragoudas E S, Egan K M, Seddon J M, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991; 98: 383–389, discussion 390
   PubMed Web of Science ®Google Scholar
• Kath R, Hayungs J, Bornfeld N, Sauerwein W, Hoffken K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer. 1993; 72: 2219–2223
   PubMed Web of Science ®Google Scholar
• Figueiredo A, Caissie A L, Callejo S A, McLean I W, Gold P, Burnier M N, Jr. Cyclooxygenase-2 expression in uveal melanoma: Novel classification of mixed cell-type tumors. Can J Ophthalmol 2003; 38: 352–356
   PubMed Web of Science ®Google Scholar
• Roche-Nagle G, Connolly E M, Eng M, Bouchier-Hayes D J, Harmey J H. Antimetastatic activity of a cyclooxygenase-2 inhibitor. Br J Cancer. 2004; 91: 359–365
   PubMed Web of Science ®Google Scholar
• Roh J L, Sung M W, Park S W, Heo D S, Lee D W, Kim K H. Celecoxib can prevent tumor growth and distant metastasis in postoperative setting. Cancer Res. 2004; 64: 3230–3235
   PubMed Web of Science ®Google Scholar
• Yao M, Lam E C, Kelly C R, Zhou W, Wolfe M M. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Br J Cancer. 2004; 90: 712–719
   PubMed Web of Science ®Google Scholar
• Ju W K, Neufeld A H. Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina. J Comp Neurol. 2002; 452: 392–399
   PubMed Web of Science ®Google Scholar
• Maihofner C, Schlotzer-Schrehardt U, Guhring H, et al. Expression of cyclooxygenase-1 and-2 in normal and glaucomatous human eyes. Invest Ophthalmol Vis Sci. 2001; 42: 2616–2624
   PubMed Web of Science ®Google Scholar
• Neufeld A H, Hernandez M R, Gonzalez M, Geller A. Cyclooxygenase-1 and cyclooxygenase-2 in the human optic nerve head. Exp Eye Res. 1997; 65: 739–745
   PubMed Web of Science ®Google Scholar
• Kelly L M, Hill A D, Kennedy S, et al. Lack of prognostic effect of Cox-2 expression in primary breast cancer on short-term follow-up. Eur J Surg Oncol. 2003; 29: 707–710
   PubMed Web of Science ®Google Scholar
• Diener-West M, Hawkins B S, Markowitz J A, Schachat A P. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992; 110: 245–250
   PubMed Web of Science ®Google Scholar
• All-Ericsson C, Girnita L, Seregard S, Bartolazzi A, Jager M J, Larsson O. Insulin-like growth factor-1 receptor in uveal melanoma: A predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci. 2002; 43: 1–8
   PubMed Web of Science ®Google Scholar
• Smith S L, Damato B E, Scholes A G, Nunn J, Field J K, Heighway J. Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival. Br J Cancer. 2002; 87: 1308–1313
   PubMed Web of Science ®Google Scholar
• Khuri F R, Wu H, Lee J J, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res. 2001; 7: 861–867
   PubMed Web of Science ®Google Scholar
• Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 2002; 62: 632–635
   PubMed Web of Science ®Google Scholar
• Sheehan K M, Sheahan K, O'Donoghue D P, et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA. 1999; 282: 1254–1257
   PubMed Web of Science ®Google Scholar
• Tomozawa S, Tsuno N H, Sunami E, et al. Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer. 2000; 83: 324–328
   PubMed Web of Science ®Google Scholar
• Xue Y W, Zhang Q F, Zhu Z B, Wang Q, Fu S B. Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma. World J Gastroenterol. 2003; 9: 250–253
   PubMed Web of Science ®Google Scholar
• Chen W S, Wei S J, Liu J M, Hsiao M, Kou-Lin J, Yang W K. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. Int J Cancer. 2001; 91: 894–899
   PubMed Web of Science ®Google Scholar
• Marshall J C, Fernandes B F, Di Cesare S, et al. The use of a cyclooxygenase-2 inhibitor (Nepafenac) in an ocular and metastatic animal model of uveal melanoma. Carcinogenesis. 2007; 28: 2053–58
   PubMed Web of Science ®Google Scholar
• Onken M D, Worley L A, Ehlers J P, Harbour J W. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004; 64: 7205–7209
   PubMed Web of Science ®Google Scholar
• Tschentscher F, Husing J, Holter T, et al. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res. 2003; 63: 2578–2584
   PubMed Web of Science ®Google Scholar
• Paraoan L, Gray D, Hiscott P, Ebrahimi B, Damato B, Grierson I. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: Downregulation is associated with aggressive type. Exp Eye Res. 2006; 83: 911–919
   PubMed Web of Science ®Google Scholar
• Fernandez N, Gonzalez A, Valera I, Alonso S, Crespo M S. Mannan and peptidoglycan induce COX-2 protein in human PMN via the mammalian target of rapamycin. Eur J Immunol. 2007; 37: 2572–2582
   PubMed Web of Science ®Google Scholar
• Gupta R A, Tejada L V, Tong B J, et al. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res. 2003; 63: 906–911
   PubMed Web of Science ®Google Scholar
• Hase T, Yoshimura R, Matsuyama M, et al. Cyclooxygenase-1 and-2 in human testicular tumors. Eur J Cancer. 2003; 39: 2043–2049
   PubMed Web of Science ®Google Scholar
• Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst. 1998; 90: 455–460
   PubMed Web of Science ®Google Scholar
• Fitzgerald G A. Coxibs and cardiovascular disease. N Engl J Med. 2004; 351: 1709–1711
   PubMed Web of Science ®Google Scholar